Kenneth Martindale - Rite Aid Pres and CEO of Rite Aid Stores

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

Fiscal Quarter End: 31st of August 2020  

  CEO
Mr. Kenneth A. Martindale is President Rite Aid Corporationrationration, Chief Executive Officer Rite Aid stores of the Company. He was appointed CEO of Rite Aid Stores effective August 3, 2015. Mr. Martindale continues to serve as President, the title he has held since June 2013. He has previously served as Rite Aid Chief Operating Officer since June 2010. From December 2008 until June 2010, he served as Rite Aid Senior Executive Vice President and Chief Merchandising, Marketing and Logistics Officer. Mr. Martindale served as CoPresident, Chief Merchandising and Marketing Officer for Pathmark Stores, Inc. from January 2006 until its acquisition by the Great Atlantic Pacific Tea Company in December 2007. In January 2000, Mr. Martindale joined the Board of Directors of Intesource, Inc. became Chairman of the Board in March 2004 and served as President, Chief Executive Officer and Chairman of the Board from November 2004 until January 2006. From September 1999 until November 2004, Mr. Martindale was Principal of Martindale Development Group, L.L.C. From September 1999 until July 2003, Mr. Martindale was Managing DirectorCEO of Orchard Street, Inc., a privately held specialty food retailer which he founded and owned. Mr. Martindale was Executive Vice President of Sales and Procurement with Fred Meyer, Inc. from January 1998 until September 1999 and was Senior Vice President of Sales and Procurement with Smith Food Drug Centers, Inc. from June 1996 until January 1998. Mr. Martindale currently serves on the Board of Directors of the National Association of Chain Drug Stores.
Age: 56  CEO Since 2015      
717 975-5905  www.riteaid.com

Kenneth Martindale Latest Insider Activity

Rite Aid Management Efficiency

Rite Aid has Return on Asset of 1.9 % which means that on every $100 spent on asset it made $1.9 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (53.68) %, meaning that it generated no profit with money invested by stockholders. Rite Aid management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Rite Aid Return on Invested Capital is expected to slightly increase based on the last few years of reporting. The past year's Return on Invested Capital was at 0.07. The current year Return on Sales is expected to grow to 0.0301, whereas Return on Average Assets are expected to decline to (5.45) . Rite Aid Goodwill and Intangible Assets are expected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 447.84 Million. The current year Revenue to Assets is expected to grow to 2.98, whereas Assets Non Current are expected to decline to about 3.8 B. Rite Aid Tax Liabilities is expected to increase significantly based on the last few years of reporting. The past year's Tax Liabilities was at 66.34 Million
The company has 6.53 B in debt. Rite Aid has a current ratio of 1.44, which is typical for the industry and considered as normal.

Similar Executives

Found 10 records

CEO Since

Shon BoneySprouts Farmers Market
2018
Jill SoltauJ C Penney
2018
Marvin EllisonJ C Penney
N/A
Christian BrickmanSally Beauty Holdings
2015
Kevin HouricanSysco
2020
William DeLaneySysco
2016
Amin MarediaSprouts Farmers Market
N/A
Andreas RouveSpectrum Brands Holdings
2015
Jack SinclairSprouts Farmers Market
2019
Myron UllmanJ C Penney
2015

Company Summary

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in the United States and is traded on BATS Exchange. It employs 29840 people.Rite Aid (RAD) is traded on BATS Exchange in USA and employs 29,840 people.

Rite Aid Leadership Team

Heyward Donigan, President, Chief Executive Officer, Director
Joseph Anderson, Independent Director
Elizabeth Burr, Independent Director
Douglas Donley, Chief Accounting Officer, Senior Vice President
Jim Peters, Chief Operating Officer
Michael Regan, Lead Independent Director
Arun Nayar, Independent Director
Brian Hoover, Chief Accounting Officer
David Jessick, Independent Director
Katherine Quinn, Independent Director
Myrtle Potter, Director
Bruce Bodaken, Independent Chairman of the Board
Kevin Lofton, Independent Director
Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer
David Abelman, Executive Vice President - Marketing
Frank Savage, Independent Director
Kermit Crawford, President COO
Marcy Syms, Independent Director
James Comitale, Senior Vice President General Counsel, Secretary
Steve Rempel, Senior Vice President CIO
Justin Mennen, Senior Vice President, Chief Information Officer
Dedra Castle, Chief Human Resource Officer, Executive Vice President
Erik Keptner, Senior Vice President Chief Marketing Officer
Marc Strassler, Corporate Counsel
Kenneth Martindale, Pres and CEO of Rite Aid Stores
Derek Griffith, Executive Vice President - Store Operations
Enio Montini, Executive Vice President - Merchandising
Louis Miramontes, Independent Director
Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP
Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations
Matthew Schroeder, Chief Financial Officer, Senior Vice President
Robert Knowling, Independent Director
Andre Persaud, Executive Vice President - Retail
Bryan Everett, Executive Vice President - Store Operations
Doug Donley, Chief Accounting Officer, Senior Vice President
John Standley, Chairman, CEO and Chairman of Executive Committee
James Peters, Chief Operating Officer

Stock Performance Indicators

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Currently Active Assets on Macroaxis

S   
Sold over 300 shares of
six days ago
Traded for 8.62
GM   
Sold over 100 shares of
six days ago
Traded for 25.24
XOM   
Sold over 60 shares of
six days ago
Traded for 44.08
OTPBF   
Sold over 100 shares of
six days ago
Traded for 28.82
MSFT   
Sold few shares of
six days ago
Traded for 206.26
Additionally, take a look at Your Equity Center. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page